http://orcid.org/0000-0003-0381-8302
References
- Holton J, Figura N, Vaira B. Helicobacter pylori. In: An atlas of investigation and management. Oxford: Clinical Publishing; 2012.
- De Francesco V, Bellesia A, Ridola L, et al. First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines. Ann Gastroenterol. 2017;30:373–379.
- Zullo A, De Francesco V, Hassan C. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks. J Clin Gastroenterol. 2012;46:259–261.
- Gatta L, Vakil N, Vaira D, et al. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587
- Thung I, Aramin H, Vavinskaya V, et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43:514–533.
- Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection - the Maastricht V/Florence consensus report. Gut. 2017;66:6–30.
- Vaira D, Gatta L, Ricci C, et al. A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic. Intern Emerg Med. 2010;1:41–47.
- Fiorini G, Vakil N, Zullo A, et al. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection. Clin Gastroenterol Hepatol. 2013;11:507–510.
- EUCAST Clinical Breakpoint Table v. 5.0, valid from 2015-01-01. Available from: http://www.eucast.org/clinical_breakpoints/±
- Di Giulio M, Di Campli E, Di Bartolomeo S, et al. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy. Scand J Gastroenterol. 2016;51:263–269.
- Mascellino MT, Porowska B, De Angelis M, et al. Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection. DDDT. 2017;11:2209–2220.
- Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. GUT. 2013;62:34–42.
- Manfredi M, Gismondi P, Maffini V, et al. Primary antimicrobial susceptibility changes in children with Helicobacter pylori Infection over 13 Years in Northern Italy. Gastroenterol Res Pract. 2015;2015:717349.
- Fasciana T, Calà C, Bonura C, et al. Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily. J Med Microbiol. 2015;64:1408–1414.
- Glupczynski Y, Megraud F, Lopez-Brea M, et al. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 2001;20:820–823.